Key points are not available for this paper at this time.
The application of Blockchain to enhance the industry's social economic resilience is widely of concern in the science, technology, and pharmaceutical industries. The research discusses the resilience of the Active Pharmaceutical Ingredient (API) in the face of global health challenges and how blockchain can improve supply chain transparency and efficiency through its unique distributed ledger (DLT) technology. The report uses literature review methods to analyze the application of blockchain technology to real-time data sharing in the API supply chain and its impact on improving API supply chain adaptability, optimizing resource allocation, and enhancing risk management capabilities. As can be seen from the result, through the real-time data sharing by the distributed ledger (DLT), the API supply chain can more effectively respond to the fluctuation of the environment and market to enhance its social and economic resilience. This research demonstrates the potential of blockchain technology in optimizing pharmaceutical supply chain management to safeguard human health and well-being.
Yuan He (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: